Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-31

Clinical Trial Update: Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

View source ↗

Summary

This clinical trial update reports the completion of an extended drug utilization study evaluating adverse events among patients exposed to ticagrelor, clopidog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRILINTA (ticagrelor)
  • EFFIENT (prasugrel hydrochloride)
  • Plavix (clopidogrel)

Snippet

Sponsor: AstraZeneca | Conditions: Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout | Status: COMPLETED